Calliditas Therapeutics AB (FRA:LC8)
€ 17.76 -0.1 (-0.56%) Market Cap: 980.76 Mil Enterprise Value: 999.32 Mil PE Ratio: 0 PB Ratio: 104.40 GF Score: 54/100

Calliditas Therapeutics AB (FRA:LC8) Transcripts

  • 1